Segment Reporting (Tables)

6 Months Ended

Jun. 30, 2014

Segment Reporting [Abstract]

Segment Reporting Information By Segment

A reconciliation of the totals reported for the reportable segments to the applicable line items in our accompanying unaudited condensed consolidated statements of operations is as follows:

	Three Months Ended June 30,						Six Months Ended June 30,
(in millions)	2014			2013			2014			2013
				(restated)						(restated)
Net sales
Interventional Cardiology	$	528		$	521		$	1,029		$	1,019
Peripheral Interventions	210			204			414			397
Cardiovascular	738			725			1,443			1,416
Cardiac Rhythm Management	495			476			959			951
Electrophysiology	55			36			113			70
Rhythm Management	550			512			1,072			1,021
Endoscopy	334			320			650			620
Urology and Women's Health	133			124			259			241
Neuromodulation	114			111			223			200
MedSurg	581			555			1,132			1,061
Net sales allocated to reportable segments	1,869			1,792			3,647			3,498
Sales generated from divested businesses	1			19			3			55
Impact of foreign currency fluctuations	3			(2		)	(3		)	17
	$	1,873		$	1,809		$	3,647		$	3,570
Income (loss) before income taxes
Cardiovascular	$	193		$	182		$	364		$	340
Rhythm Management	67			56			133			113
MedSurg	175			171			343			311
Operating income allocated to reportable segments	435			409			840			764
Corporate expenses and currency exchange	(64		)	(48		)	(115		)	(89		)
Goodwill and other intangible asset impairment charges; and acquisition-, divestiture-, restructuring-, and litigation related charges or credits	(331		)	(40		)	(379		)	(580		)
Amortization expense	(109		)	(101		)	(218		)	(204		)
Operating income (loss)	(69		)	220			128			(109		)
Other expense, net	(35		)	(68		)	(86		)	(133		)
Income (loss) before income taxes	$	(104	)	$	152		$	42		$	(242	)